Premium
Virpax Pharmaceuticals Inc (VRPX)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray. Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.021 | 6.06936416185 | 0.346 | 0.463 | 0.3068 | 1551868 | 0.38897094 | CS |
| 4 | -0.0976 | -21.0073181231 | 0.4646 | 0.48 | 0.286 | 1409117 | 0.37942648 | CS |
| 12 | -0.296 | -44.6455505279 | 0.663 | 1.05 | 0.286 | 6450204 | 0.55131695 | CS |
| 26 | -0.133 | -26.6 | 0.5 | 3.39 | 0.286 | 5972548 | 0.97512609 | CS |
| 52 | -2.693 | -88.0065359477 | 3.06 | 5.48 | 0.286 | 3091272 | 0.98905572 | CS |
| 156 | -31.333 | -98.8422712934 | 31.7 | 36.7 | 0.286 | 1089951 | 1.70366571 | CS |
| 260 | -79.633 | -99.54125 | 80 | 359.799 | 0.286 | 1347849 | 43.38496198 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
